Pharmacological Characterisation of Cortical γ-Aminobutyric Acid Type A (GABAA) Receptors in Two Wistar Rat Lines Selectively Bred for High and Low Anxiety-Related Behaviour

World Journal of Biological Psychiatry - Tập 1 Số 3 - Trang 137-143 - 2000
Bettina Hermann1, Rainer Landgraf2, Martin E. Keck3, Alexandra Wigger1, A. Leslie Morrow4, Andreas Ströhle1, Herta Flor5, Rainer Rupprecht6
1Max-Planck-Institute of Psychiatry, Munich, Germany
2AG Landgraf, Rainer, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society
3Max Planck Institute of Psychiatry, Max Planck Society
4University of North Carolina at Chapel Hill, Chapel Hill, NC USA
5Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society
6Rainer Rupprecht (Max-Planck Fellow), Max Planck Institute of Psychiatry, Max Planck Society

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abadie P, 1999, Eur J Neurosci, 11, 1470, 10.1046/j.1460-9568.1999.00556.x

Bentareha R, 1998, Eur J Pharmacol, 354, 91, 10.1016/S0014-2999(98)00428-2

Boyer W, 1995, Int Clin Psychopharmacol, 10, 45, 10.1097/00004850-199503000-00006

Bradwejn J, 1991, Arch Gen Psychiatry, 48, 603, 10.1001/archpsyc.1991.01810310021005

Brawman-Mintzer O, 1997, J Clin Psychiatry, 58, 16, 10.4088/JCP.v58n0103

Carr D B., 1986, Am J Psychiatry, 143, 483, 10.1176/ajp.143.4.483

de Montigny C, 1989, Arch Gen Psychiatry, 46, 511, 10.1001/archpsyc.1989.01810060031006

Devaud L L., 1994, Eur J Pharmacol, 267, 243, 10.1016/0922-4106(94)90177-5

Giorgi O, 1994, Brain Res, 638, 133, 10.1016/0006-8993(94)90642-4

Goddard A W., 1997, J Clin Psychiatry, 58, 4

Goodnough D B., 1995, Eur J Pharmacol Mol Pharmacol Section, 288, 157, 10.1016/0922-4106(95)90190-6

Gorman J M., 1997, Biol Psychiatry, 42, 982, 10.1016/S0006-3223(97)00160-1

Griebel G, 1999, Pharmacol Ther, 82, 1, 10.1016/S0163-7258(98)00041-2

10.1016/0165-6147(90)90126-S

10.1016/0165-6147(93)90020-K

Hauser C AE, 1995, Eur J Pharmacol, 289, 249, 10.1016/0922-4106(95)90101-9

Hauser C AE, 1997, J Biol Chem, 272, 11723, 10.1074/jbc.272.18.11723

Holsboer F, 1992, Prog Brain Res, 93, 385, 10.1016/S0079-6123(08)64586-0

Imamura M, 1998, Physiol Behav, 64, 415, 10.1016/S0031-9384(98)00105-X

Janis C C., 1998, Alcoholism: Clinical and Experimental Research, 22, 2055

10.1126/science.281.5383.1640

10.1016/S0165-6147(00)89058-6

Landgraf R, 1999, J Neuroendocrinol, 11, 405, 10.1046/j.1365-2826.1999.00342.x

Lecrubier Y, 1997, Acta Psychiatr Scand, 95, 145, 10.1111/j.1600-0447.1997.tb00388.x

Liebsch G, 1998, Behav Brain Res, 94, 301, 10.1016/S0166-4328(97)00198-8

Liebsch G, 1998, Neuropsychopharmacology, 19, 381, 10.1016/S0893-133X(98)00042-6

Munson P J., 1980, Anal Biochem, 107, 220, 10.1016/0003-2697(80)90515-1

Oehrberg S, 1995, Br J Psychiatry, 167, 374, 10.1192/bjp.167.3.374

Olsen R W., 1990, FASEB J, 4, 1469, 10.1096/fasebj.4.5.2155149

Paul S M., 1992, FASEB J, 6, 2311, 10.1096/fasebj.6.6.1347506

Prasad A, 1997, Physiol Behav, 62, 1053, 10.1016/S0031-9384(97)00239-4

10.1126/science.2551039

Purdy R H., 1991, Proc Natl Acad Sci USA, 8, 4553, 10.1073/pnas.88.10.4553

Rupprecht R, 1999, Trends Neurosci, 22, 410, 10.1016/S0166-2236(99)01399-5

Sheehan D V., 1996, J Clin Psychiatry, 57, 51

Steimer P, 1997, J Neuroendocrinol, 9, 169, 10.1046/j.1365-2826.1997.t01-1-00571.x

Ströhle A, 1997, Neuroendocrinology, 65, 210, 10.1159/000127274

Timpl P, 1998, Nature Gen, 19, 162, 10.1038/520

Treit D, 1985, Neurosci Biobehav Rev, 9, 203, 10.1016/0149-7634(85)90046-6

Wisden W, 1992, Curr Opinion Neurobiol, 2, 263, 10.1016/0959-4388(92)90113-Y